Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOBR Safe, Inc. Director's Dealing 2020

Jan 14, 2020

35413_dirs_2020-01-14_a005f4df-bb82-4f87-89b3-f8df89c2fa51.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TransBiotec, Inc. (IMLE)
CIK: 0001425627
Period of Report: 2019-10-25

Reporting Person: Gandini David Joseph (Director, Chief Revenue Officer)